Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.

Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G, Carreira PE, Caramaschi P, Ananieva LP, Matucci-Cerinic M, Czirjak L, Denton C, Ladner UM, Allanore Y; EUSTAR collaborators*; EUSTAR collaborators.

Ann Rheum Dis. 2016 Jan;75(1):103-9. doi: 10.1136/annrheumdis-2014-205295. Epub 2014 Aug 27.

PMID:
25165035
2.

Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis.

Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U, Haeupl T, Hanke K, Hensel-Wiegel K, Ebert H, Ziemer S, Ladner UM, Pirlich M, Burmester GR, Riemekasten G.

Ann Rheum Dis. 2010 Nov;69(11):1951-7. doi: 10.1136/ard.2009.123273. Epub 2010 May 28.

PMID:
20511612
3.

The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma research.

Tyndall A, Ladner UM, Matucci-Cerinic M.

Curr Opin Rheumatol. 2008 Nov;20(6):703-6. doi: 10.1097/BOR.0b013e328311f841. Review.

PMID:
18946332

Supplemental Content

Loading ...
Support Center